Home > Press > NVE Notified of Grant of Magnetothermal MRAM Patent
Abstract:
NVE Corporation (Nasdaq:NVEC) announced today that it has been notified by the U.S. Patent and Trademark Office (USPTO) of the expected grant of a patent relating to magnetothermal Magnetoresistive Random Access Memory (MRAM).
NVE has been notified that the patent, titled "Magnetic Memory Layers Thermal Pulse Transitions," will be issued today. The patent is number 7,177,178 and is the grant of a patent under the application published by the USPTO as number 2006 0083056. The grant is in addition to patent number 7,023,723, which is similarly titled and was granted in April 2006. The invention of the new patent relates to dual-film MRAM cells.
MRAM is an integrated-circuit memory which is fabricated with nanotechnology and which uses electron spin to store data. MRAM may have the potential to combine many of the best attributes of different types of semiconductor memories.
Magnetothermal MRAM uses a combination of ultra-fast magnetic fields and heat pulses, both from electrical current, to reduce the energy required to write data and allow reduction of the memory cell size while maintaining thermal stability.
The grant brings NVE's U.S. patent total to 40. The company has more than 100 patents worldwide issued, pending, or licensed from others. Links to the new patent and NVE's other U.S. patents can be found at the "About NVE" section of the company's Website ( http://www.nve.com ).
####
About NVE Corporation
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that many experts believe represents the next generation of microelectronics. NVE licenses its MRAM intellectual property and sells spintronic products, including sensors and couplers, to revolutionize data sensing and transmission.
Statements used in this press release that relate to future plans, events, financial results or performance are forward-looking statements that are subject to certain risks and uncertainties including, among others, such factors as uncertainties relating to the grant of patents in the future, risks in the enforcement of our patents, as well as the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10 K and other reports filed with the SEC. 
For more information, please click here
Contacts:
NVE Corporation
Curt A. Reynders
Chief Financial Officer
(952) 829-9217
Copyright © PrimeNewswire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
| Related News Press | 
Chip Technology
    Lab to industry: InSe wafer-scale breakthrough for future electronics August 8th, 2025
    A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
    Programmable electron-induced color router array May 14th, 2025
Nanoelectronics
    Lab to industry: InSe wafer-scale breakthrough for future electronics August 8th, 2025
    Interdisciplinary: Rice team tackles the future of semiconductors Multiferroics could be the key to ultralow-energy computing October 6th, 2023
    Key element for a scalable quantum computer: Physicists from Forschungszentrum Jülich and RWTH Aachen University demonstrate electron transport on a quantum chip September 23rd, 2022
    Reduced power consumption in semiconductor devices September 23rd, 2022
Announcements
    Rice membrane extracts lithium from brines with greater speed, less waste October 3rd, 2025
    Researchers develop molecular qubits that communicate at telecom frequencies October 3rd, 2025
    Next-generation quantum communication October 3rd, 2025
    "Nanoreactor" cage uses visible light for catalytic and ultra-selective cross-cycloadditions October 3rd, 2025
Patents/IP/Tech Transfer/Licensing
    Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
    Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
    Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
| 
			 | 
	||
| 
			 | 
	||
| The latest news from around the world, FREE | ||
| 
			 | 
	||
| 
			 | 
	||
| Premium Products | ||
| 
			 | 
	||
| 
			Only the news you want to read! 
			 Learn More  | 
		||
| 
			 | 
	||
| 
			Full-service, expert consulting 
			 Learn More  | 
		||
| 
			 | 
	||